ABSTRACT
Bladder cancer is a disease with significant heterogeneity of outcome, ranging from tumours involving mucosa, in which metastatic disease is rare, to muscle-invasive disease with poor prognosis. Management is further complicated as bladder cancer often occurs in the elderly, who frequently suffer concurrent medical conditions (often related to smoking) and may be of poor performance status, thus limiting treatment options.
